Responses
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
630 PD-L1/CD47 tumor directed B-BodyTM bispecific antibodies demonstrating significant anti-tumor activity with no toxicity in preclinical models
Compose a Response to This Article
Other responses
No responses have been published for this article.
